000 06100cam a2200637Ii 4500
001 on1029759751
003 OCoLC
005 20240729132131.0
006 m d
007 cr cnu|||unuuu
008 180329s2018 nju ob 001 0 eng d
040 _aN$T
_beng
_erda
_epn
_cN$T
_dN$T
_dYDX
_dJSTOR
_dEBLCP
020 _a9780813586434
_q(electronic bk.)
020 _a0813586437
_q(electronic bk.)
020 _z9780813586410
035 _a1455653
_b(N$T)
035 _a(OCoLC)1029759751
037 _a22573/ctt1q0fh1t
_bJSTOR
072 7 _aHEA
_x039000
_2bisacsh
072 7 _aMED
_x014000
_2bisacsh
072 7 _aMED
_x022000
_2bisacsh
072 7 _aMED
_x112000
_2bisacsh
072 7 _aMED
_x045000
_2bisacsh
072 7 _aMED078000
_2bisacsh
072 7 _aMED112000
_2bisacsh
072 7 _aMED071000
_2bisacsh
072 7 _aMED014000
_2bisacsh
072 7 _aMED010000
_2bisacsh
049 _aMAIN
245 0 0 _aIatrogenicity :
_bCauses and Consequences of Iatrogenesis in Cardiovascular Medicine
_c
_h[E-Book]
264 1 _aNew Brunswick, New Jersey :
_bRutgers University Press Medicine,
_c2018.
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
588 _aOnline resource; title from PDF title page (EBSCO, viewed March 29, 2018).
504 _aIncludes bibliographical references and index.
520 _a"Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one's expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a huge public health issue: tens to hundreds of thousands of deaths are attributed to iatrogenic causes each year in the U.S., and vulnerable populations such as the elderly and minorities are particularly susceptible. Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues. . "--
_cProvided by publisher.
505 0 _aIntro; Title Page; Copyright; Contents; Contributors; The Concept of Iatrogenicity; Part I: Medical Harm; Chapter 1. Iatrogenicity: Definition, History, and Modern Context; Chapter 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions; Chapter 3. Risk Management: The Medical Center Administration Perspective; Chapter 4. Iatrogenicity from the Patient's Perspective; Chapter 5. A Naturopathic Perspective on Iatrogenesis; Part II: Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs
505 8 _aChapter 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and SyndromesChapter 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Chapter 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension; Chapter 10. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes; Chapter 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics
505 8 _aChapter 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on PreeclampsiaChapter 13. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect; Chapter 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents; Chapter 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System; Chapter 16. Iatrogenicity and Antianginal Drugs; Chapter 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?; Chapter 18. Cardiovascular Iatrogenicity in Older Adults
505 8 _aPart III: Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and SurgeriesChapter 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology; Chapter 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology; Chapter 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries; Chapter 22. Iatrogenic Aspects of Cardiac Electrophysiology; Chapter 23. Iatrogenic Aspects in Cardiac Device Therapy
505 8 _aChapter 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic ModalitiesPart IV: Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications; Chapter 25. Trained Athletes; Chapter 26. Sports Cardiology; Chapter 27. Dangers of Lifestyle Modification Advice; Part V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine; Chapter 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications; Chapter 29. Interactions Between Supplements and Medications; Index
590 _aMaster record variable field(s) change: 072
650 0 _aCardiovascular system
_xDiseases
_xTreatment.
650 0 _aIatrogenic diseases.
700 1 _aGussak, Ihor,
_eeditor.
700 1 _aKostis, John B.,
_eeditor.
856 _u#gotoholdings
_yAccess resource
938 _aEBL - Ebook Library
_bEBLB
_nEBL4789855
938 _aYBP Library Services
_bYANK
_n15247127
938 _aYBP Library Services
_bYANK
_n15245802
938 _aEBSCOhost
_bEBSC
_n1455653
942 _n0
994 _a92
_bN$T
999 _c92577
_d92577